A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.
Some experts stated the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.
Service Reaction and Content Removal
According to TikTok, the platform has removed violative material and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within minutes of entering one group, a vendor shared contact information, where most transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Costs
Within these communities, posts show dark colored packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental product not yet authorized … may expose patients to potentially serious health risks”.
